Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Clinical Pearls.

Board R.

Am J Crit Care. 2019 Nov;28(6):413. doi: 10.4037/ajcc2019902. No abstract available.

PMID:
31676514
2.

Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement.

Peach H, Board R, Cook M, Corrie P, Ellis S, Geh J, King P, Laitung G, Larkin J, Marsden J, Middleton M, Moncrieff M, Nathan P, Powell B, Pritchard-Jones R, Rodwell S, Steven N, Lorigan P.

J Plast Reconstr Aesthet Surg. 2019 Jun 28. pii: S1748-6815(19)30299-2. doi: 10.1016/j.bjps.2019.06.020. [Epub ahead of print]

PMID:
31477493
3.

Clinical Pearls.

Board R.

Am J Crit Care. 2019 Sep;28(5):337. doi: 10.4037/ajcc2019863. No abstract available.

PMID:
31474602
4.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Corrie PG, Marshall A, Nathan PD, Lorigan P, Gore M, Tahir S, Faust G, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Goodman A, Dalgleish A, Martin-Clavijo A, Westwell S, Casasola R, Chao D, Maraveyas A, Patel PM, Ottensmeier CH, Farrugia D, Humphreys A, Eccles B, Young G, Barker EO, Harman C, Weiss M, Myers KA, Chhabra A, Rodwell SH, Dunn JA, Middleton MR.

Ann Oncol. 2019 Aug 19. pii: mdz237. doi: 10.1093/annonc/mdz237. [Epub ahead of print] No abstract available.

PMID:
31430371
5.

Clinical Pearls.

Board R.

Am J Crit Care. 2019 Jul;28(4):246. doi: 10.4037/ajcc2019988. No abstract available.

PMID:
31263005
6.

Cancer control in low- and middle-income countries: time for action.

Hack B, Piddock K, Stanway S, Balachandran K, Board R, Chopra N, Okonji D, Sirohi B, Sullivan R, Wakeham K.

J R Soc Med. 2019 Jun;112(6):213-217. doi: 10.1177/0141076819843653. Epub 2019 May 24. No abstract available.

PMID:
31124403
7.

Clinical Pearls.

Board R.

Am J Crit Care. 2019 May;28(3):170. doi: 10.4037/ajcc2019388. No abstract available.

PMID:
31043395
8.

Real-world experience with pembrolizumab toxicities in advanced melanoma patients: a single-center experience in the UK.

So AC, Board RE.

Melanoma Manag. 2018 Apr 24;5(1):MMT05. doi: 10.2217/mmt-2017-0028. eCollection 2018 Jun.

9.

Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma.

Cheshire SC, Board RE, Lewis AR, Gudur LD, Dobson MJ.

Radiology. 2018 Nov;289(2):564-567. doi: 10.1148/radiol.2018180572. Epub 2018 Aug 14.

PMID:
30106351
10.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Corrie PG, Marshall A, Nathan PD, Lorigan P, Gore M, Tahir S, Faust G, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Goodman A, Dalgleish A, Martin-Clavijo A, Westwell S, Casasola R, Chao D, Maraveyas A, Patel PM, Ottensmeier CH, Farrugia D, Humphreys A, Eccles B, Young G, Barker EO, Harman C, Weiss M, Myers KA, Chhabra A, Rodwell SH, Dunn JA, Middleton MR; AVAST-M Investigators.

Ann Oncol. 2018 Aug 1;29(8):1843-1852. doi: 10.1093/annonc/mdy229.

11.

Managing side effects of cancer immunotherapy for the acute physician.

Pickwell-Smith BA, So AC, Board RE.

Br J Hosp Med (Lond). 2018 Jul 2;79(7):372-377. doi: 10.12968/hmed.2018.79.7.372.

PMID:
29995540
12.

Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios.

Gray E, Butler HJ, Board R, Brennan PM, Chalmers AJ, Dawson T, Goodden J, Hamilton W, Hegarty MG, James A, Jenkinson MD, Kernick D, Lekka E, Livermore LJ, Mills SJ, O'Neill K, Palmer DS, Vaqas B, Baker MJ.

BMJ Open. 2018 May 24;8(5):e017593. doi: 10.1136/bmjopen-2017-017593.

13.

Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.

Lim KHJ, Spain L, Barker C, Georgiou A, Walls G, Gore M, Turajlic S, Board R, Larkin JM, Lorigan P.

ESMO Open. 2018 Feb 24;3(2):e000317. doi: 10.1136/esmoopen-2017-000317. eCollection 2018.

14.

Metastatic melanoma: prognostic factors and survival in patients with brain metastases.

Frinton E, Tong D, Tan J, Read G, Kumar V, Kennedy S, Lim C, Board RE.

J Neurooncol. 2017 Dec;135(3):507-512. doi: 10.1007/s11060-017-2591-9. Epub 2017 Aug 17.

15.

Mother's Lived Experience During Repair of Long-Gap Esophageal Atresia: A Phenomenological Inquiry.

Fleck P, Kenner C, Board R, Mott S.

Adv Neonatal Care. 2017 Aug;17(4):313-323. doi: 10.1097/ANC.0000000000000415.

PMID:
28570293
16.

A review of novel analytical diagnostics for liquid biopsies: spectroscopic and spectrometric serum profiling of primary and secondary brain tumors.

Spalding K, Board R, Dawson T, Jenkinson MD, Baker MJ.

Brain Behav. 2016 Jun 29;6(9):e00502. eCollection 2016 Sep. Review.

17.

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.

Baird R, Banks I, Cameron D, Chester J, Earl H, Flannagan M, Januszewski A, Kennedy R, Payne S, Samuel E, Taylor H, Agarwal R, Ahmed S, Archer C, Board R, Carser J, Copson E, Cunningham D, Coleman R, Dangoor A, Dark G, Eccles D, Gallagher C, Glaser A, Griffiths R, Hall G, Hall M, Harari D, Hawkins M, Hill M, Johnson P, Jones A, Kalsi T, Karapanagiotou E, Kemp Z, Mansi J, Marshall E, Mitchell A, Moe M, Michie C, Neal R, Newsom-Davis T, Norton A, Osborne R, Patel G, Radford J, Ring A, Shaw E, Skinner R, Stark D, Turnbull S, Velikova G, White J, Young A, Joffe J, Selby P.

Ecancermedicalscience. 2016 Jan 5;10:608. doi: 10.3332/ecancer.2016.608. eCollection 2016.

18.

A Comparison of Antibiotic Serum Concentrations Drawn Simultaneously from Peripherally Inserted Central Catheters and Peripheral Veins in Children with Respiratory Infection.

Green ME, Sullivan KJ, Wells S, Board R, Feldman HA, McCabe M.

J Pediatr Nurs. 2015 Nov-Dec;30(6):868-76. doi: 10.1016/j.pedn.2015.07.011. Epub 2015 Sep 15.

PMID:
26382967
19.

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients.

Ahmad SS, Qian W, Ellis S, Mason E, Khattak MA, Gupta A, Shaw H, Quinton A, Kovarikova J, Thillai K, Rao A, Board R, Nobes J, Dalgleish A, Grumett S, Maraveyas A, Danson S, Talbot T, Harries M, Marples M, Plummer R, Kumar S, Nathan P, Middleton MR, Larkin J, Lorigan P, Wheater M, Ottensmeier CH, Corrie PG.

Melanoma Res. 2015 Oct;25(5):432-42. doi: 10.1097/CMR.0000000000000185.

20.

The assessment of deaths after radiotherapy is an essential part of service evaluation—results of a 30 day mortality audit of patient deaths after palliative radiotherapy.

Boardman A, Clements H, Kellett D, Mitchell C, Board R.

Clin Oncol (R Coll Radiol). 2014 Dec;26(12):807. doi: 10.1016/j.clon.2014.09.005. Epub 2014 Sep 26. No abstract available.

PMID:
25262844

Supplemental Content

Loading ...
Support Center